Evidence map›Paper›PMID 25221396›Full record

ArticleAnnals of Indian Academy of Neurology2014

Major outcomes of patients with tuberculous meningitis on directly observed thrice a week regime.

Thomas Iype, Ayyappan Kunjukrishna Pillai, Ajith Cherian, Zinia T Nujum, Chithra Pushpa, Dalus Dae, Vijayakumar Krishnapillai

Open access · diamondAbstract read
In one paragraph

Article in Annals of Indian Academy of Neurology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Six months therapy for tuberculous meningitis.The Cochrane database of systematic reviews · 2016
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Thomas IypeDepartment of Neurology, Government Medical College, Thiruvananthapuram, Kerala, India.
Ayyappan Kunjukrishna PillaiDepartment of Neurology, Government Medical College, Thiruvananthapuram, Kerala, India.
Ajith CherianDepartment of Neurology, Government Medical College, Thiruvananthapuram, Kerala, India.
Zinia T NujumDepartment of Community Medicine, Government Medical College, Thiruvananthapuram, Kerala, India.
Chithra PushpaDepartment of Neurology, Government Medical College, Thiruvananthapuram, Kerala, India.
Dalus DaeDepartment of Medicine, Government Medical College, Thiruvananthapuram, Kerala, India.
Vijayakumar KrishnapillaiDepartment of Community Medicine, Government Medical College, Thiruvananthapuram, Kerala, India.
Government Medical College · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRevised National Tuberculosis Control Programme (RNTCP) of Government of India provides intermittent thrice-a-week directly observed treatment short course (RNTCP regimen).

objectiveAssessments of all-cause mortality and nine-month morbidity outcomes of patients with tuberculous meningitis (TBM) on RNTCP regimen. MATERIALS AND

methodsWe prospectively followed up patients registered with RNTCP center, with a diagnosis of TBM from January 1(st), 2010 to December 31(st), 2011. Morbidity was assessed using modified Rankin Scale (mRS).

resultsWe had 43 patients with median duration for follow-up of 396 days and that of survivors of 425 days. Two patients defaulted. Fourteen patients (32.5%) had mRS score of 4 to 6 and 29 had mRS of 0 to 3 after 9-month treatment. Severe disability was not related to any factor on logistic regression. Severe disability was seen in one patient (6.66%) among the 15 patients with stage 1, nine (37.5%) out of 24 patients with stage 2 and three (75%) out of 4 patients with stage 3 disease. Eight patients died (18.6%) of whom 4 died during the intensive phase and 4 during the continuation phase of RNTCP regimen. Mortality was independently related to treatment failure with adjusted Hazard ratio of 8.29 (CI: 1.38-49.78) (P = 0.02). One patient (6.66%) died out of the 15 patients with stage 1 disease, 5 (20.8%) out of 24 patients with stage 2 disease and 2 (50%) out of the 4 with stage 3 disease. DISCUSSION AND

conclusionRNTCP regimen was associated with good compliance, comparable mortality and morbidity.

Indexed as

Meningeal Tuberculosismorbiditymortalityprognosistreatment

Identifiers

PMID25221396
PMCPMC4162013
OpenAlexW2131341312

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.